BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

17 related articles for article (PubMed ID: 1786815)

  • 1. Non-targeted metabolomics analysis of cardiac Muscle Ring Finger-1 (MuRF1), MuRF2, and MuRF3 in vivo reveals novel and redundant metabolic changes.
    Banerjee R; He J; Spaniel C; Quintana MT; Wang Z; Bain J; Newgard CB; Muehlbauer MJ; Willis MS
    Metabolomics; 2015 Apr; 11(2):312-322. PubMed ID: 28325996
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [The characteristics of the cardioprotective action of fructose-1,6-diphosphate].
    Sernov LN; Rozonov IuB; Sokolova OA; Shal'neva TV; Snegireva GV; Gatsura VV
    Biull Eksp Biol Med; 1991 Feb; 111(2):172-3. PubMed ID: 1854962
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [The effect of fructose-1,6-diphosphate, cytochrome c and their combination on the size of the necrotic area in transient myocardial ischemia].
    Imatdieva RM; Gatsura VV
    Eksp Klin Farmakol; 1997; 60(1):32-4. PubMed ID: 9162279
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Effect of fructose-1,6-diphosphate on the size of the necrotic area and course of the acute period of experimental myocardial infarction in rats].
    Sernov LN; Snegireva GV; Gatsura VV
    Kardiologiia; 1989 Aug; 29(8):66-9. PubMed ID: 2585964
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [A comparative evaluation of the cardioprotective and antianginal actions of energy-providing agents].
    Sernov LN; Rozonov IuB; Gatsura VV
    Eksp Klin Farmakol; 1992; 55(4):13-5. PubMed ID: 1458176
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inability of fructose 1,6-diphosphate to reduce myocardial infarct size.
    Brown EJ; Erburu L; Kloner RA
    J Med; 1987; 18(1):43-53. PubMed ID: 3474341
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [The antiacidotic and cardioprotective effects of fructose-1,6-diphosphate and dehydroascorbic acid].
    Sernov LN; Sokolova OA; Gatsura VV
    Farmakol Toksikol; 1991; 54(4):24-6. PubMed ID: 1786815
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [-Myocardial protection by preconditioning. Experimental and clinical significance-].
    Strasser R; Vogt A; Schaper W
    Z Kardiol; 1996 Feb; 85(2):79-89. PubMed ID: 8650986
    [TBL] [Abstract][Full Text] [Related]  

  • 9.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 10.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 11.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 12.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 13.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 14.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 15.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 1.